MMT Trademark

Trademark Overview


On Wednesday, December 19, 2018, a trademark application was filed for MMT with the United States Patent and Trademark Office. The USPTO has given the MMT trademark a serial number of 88235670. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 28, 2022. This trademark is owned by Kaleido Biosciences, Inc.. The MMT trademark is filed in the Pharmaceutical Products category with the following description:

therapeutic pharmaceuticals for medical use for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; dietetic foods adapted for medical use; dietary supplements; nutritional supplements; nutraceuticals for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders...
mmt

General Information


Serial Number88235670
Word MarkMMT
Filing DateWednesday, December 19, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 28, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 27, 2019

Trademark Statements


Goods and Servicestherapeutic pharmaceuticals for medical use for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; dietetic foods adapted for medical use; dietary supplements; nutritional supplements; nutraceuticals for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; medical diagnostic reagents and assays for testing body fluids for microorganisms for modifying the microbial composition or metabolic output of the human microbiome

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 11, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKaleido Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Party NameKaleido Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events


Event DateEvent Description
Monday, November 28, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 28, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 27, 2022SOU EXTENSION 5 GRANTED
Friday, April 22, 2022SOU EXTENSION 5 FILED
Wednesday, April 27, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 22, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 15, 2021SOU EXTENSION 4 GRANTED
Friday, October 15, 2021SOU EXTENSION 4 FILED
Friday, October 15, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 16, 2021SOU EXTENSION 3 GRANTED
Friday, April 16, 2021SOU EXTENSION 3 FILED
Friday, April 16, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 16, 2020SOU EXTENSION 2 GRANTED
Friday, October 16, 2020SOU EXTENSION 2 FILED
Friday, October 16, 2020SOU TEAS EXTENSION RECEIVED
Thursday, April 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 21, 2020SOU EXTENSION 1 GRANTED
Tuesday, April 21, 2020SOU EXTENSION 1 FILED
Tuesday, April 21, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, October 22, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 27, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 7, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, July 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 27, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 27, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 25, 2019ASSIGNED TO LIE
Wednesday, June 19, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 22, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 22, 2019NON-FINAL ACTION E-MAILED
Friday, March 22, 2019NON-FINAL ACTION WRITTEN
Thursday, March 14, 2019ASSIGNED TO EXAMINER
Friday, January 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED